世界のまれな炎症性疾患の治療市場：市場規模・現状・予測

• 英文タイトル：Global Rare Inflammatory Disease Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7937 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当資料は、まれな炎症性疾患の治療のグローバル市場について調査・分析したレポートで、種類別（注射剤、経口、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・まれな炎症性疾患の治療の世界市場規模 ・主要企業別市場シェア ・まれな炎症性疾患の治療の世界市場規模：種類別（注射剤、経口、その他） ・まれな炎症性疾患の治療の世界市場規模：用途別（病院薬局、小売薬局、オンライン薬局） ・まれな炎症性疾患の治療のアメリカ市場規模（種類別、用途別） ・まれな炎症性疾患の治療のヨーロッパ市場規模（種類別、用途別） ・まれな炎症性疾患の治療の中国市場規模（種類別、用途別） ・まれな炎症性疾患の治療の日本市場規模（種類別、用途別） ・まれな炎症性疾患の治療の東南アジア市場規模（種類別、用途別） ・まれな炎症性疾患の治療のインド市場規模（種類別、用途別） ・まれな炎症性疾患の治療の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・まれな炎症性疾患の治療の世界市場予測（2019年-2025年） ・まれな炎症性疾患の治療の地域別市場予測（2019年-2025年） ...

In 2018, the global Rare Inflammatory Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Rare Inflammatory Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rare Inflammatory Disease Treatment development in United States, Europe and China.

The key players covered in this study
Pfizer
Novartis
Abbott Laboratories
Johnson & Johnson
Allergan
Abbvie
Bausch Health Companies
Mallinckrodt
Regeneron Pharmaceuticals
Swedish Orphan Biovitrum

Market segment by Type, the product can be split into
Injectables
Oral
Others

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Rare Inflammatory Disease Treatment status, future forecast, growth opportunity, key market and key players.
To present the Rare Inflammatory Disease Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Rare Inflammatory Disease Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Rare Inflammatory Disease Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Injectables
1.4.3 Oral
1.4.4 Others
1.5 Market by Application
1.5.1 Global Rare Inflammatory Disease Treatment Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Rare Inflammatory Disease Treatment Market Size
2.2 Rare Inflammatory Disease Treatment Growth Trends by Regions
2.2.1 Rare Inflammatory Disease Treatment Market Size by Regions (2014-2025)
2.2.2 Rare Inflammatory Disease Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Rare Inflammatory Disease Treatment Market Size by Manufacturers
3.1.1 Global Rare Inflammatory Disease Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Rare Inflammatory Disease Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Rare Inflammatory Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Rare Inflammatory Disease Treatment Key Players Head office and Area Served
3.3 Key Players Rare Inflammatory Disease Treatment Product/Solution/Service
3.4 Date of Enter into Rare Inflammatory Disease Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Rare Inflammatory Disease Treatment Market Size by Type (2014-2019)
4.2 Global Rare Inflammatory Disease Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Rare Inflammatory Disease Treatment Market Size (2014-2019)
5.2 Rare Inflammatory Disease Treatment Key Players in United States
5.3 United States Rare Inflammatory Disease Treatment Market Size by Type
5.4 United States Rare Inflammatory Disease Treatment Market Size by Application

6 Europe
6.1 Europe Rare Inflammatory Disease Treatment Market Size (2014-2019)
6.2 Rare Inflammatory Disease Treatment Key Players in Europe
6.3 Europe Rare Inflammatory Disease Treatment Market Size by Type
6.4 Europe Rare Inflammatory Disease Treatment Market Size by Application

7 China
7.1 China Rare Inflammatory Disease Treatment Market Size (2014-2019)
7.2 Rare Inflammatory Disease Treatment Key Players in China
7.3 China Rare Inflammatory Disease Treatment Market Size by Type
7.4 China Rare Inflammatory Disease Treatment Market Size by Application

8 Japan
8.1 Japan Rare Inflammatory Disease Treatment Market Size (2014-2019)
8.2 Rare Inflammatory Disease Treatment Key Players in Japan
8.3 Japan Rare Inflammatory Disease Treatment Market Size by Type
8.4 Japan Rare Inflammatory Disease Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Rare Inflammatory Disease Treatment Market Size (2014-2019)
9.2 Rare Inflammatory Disease Treatment Key Players in Southeast Asia
9.3 Southeast Asia Rare Inflammatory Disease Treatment Market Size by Type
9.4 Southeast Asia Rare Inflammatory Disease Treatment Market Size by Application

10 India
10.1 India Rare Inflammatory Disease Treatment Market Size (2014-2019)
10.2 Rare Inflammatory Disease Treatment Key Players in India
10.3 India Rare Inflammatory Disease Treatment Market Size by Type
10.4 India Rare Inflammatory Disease Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Rare Inflammatory Disease Treatment Market Size (2014-2019)
11.2 Rare Inflammatory Disease Treatment Key Players in Central & South America
11.3 Central & South America Rare Inflammatory Disease Treatment Market Size by Type
11.4 Central & South America Rare Inflammatory Disease Treatment Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Rare Inflammatory Disease Treatment Introduction
12.1.4 Pfizer Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Rare Inflammatory Disease Treatment Introduction
12.2.4 Novartis Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Abbott Laboratories
12.3.1 Abbott Laboratories Company Details
12.3.2 Company Description and Business Overview
12.3.3 Rare Inflammatory Disease Treatment Introduction
12.3.4 Abbott Laboratories Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)
12.3.5 Abbott Laboratories Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Rare Inflammatory Disease Treatment Introduction
12.4.4 Johnson & Johnson Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)
12.4.5 Johnson & Johnson Recent Development
12.5 Allergan
12.5.1 Allergan Company Details
12.5.2 Company Description and Business Overview
12.5.3 Rare Inflammatory Disease Treatment Introduction
12.5.4 Allergan Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)
12.5.5 Allergan Recent Development
12.6 Abbvie
12.6.1 Abbvie Company Details
12.6.2 Company Description and Business Overview
12.6.3 Rare Inflammatory Disease Treatment Introduction
12.6.4 Abbvie Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)
12.6.5 Abbvie Recent Development
12.7 Bausch Health Companies
12.7.1 Bausch Health Companies Company Details
12.7.2 Company Description and Business Overview
12.7.3 Rare Inflammatory Disease Treatment Introduction
12.7.4 Bausch Health Companies Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)
12.7.5 Bausch Health Companies Recent Development
12.8 Mallinckrodt
12.8.1 Mallinckrodt Company Details
12.8.2 Company Description and Business Overview
12.8.3 Rare Inflammatory Disease Treatment Introduction
12.8.4 Mallinckrodt Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)
12.8.5 Mallinckrodt Recent Development
12.9 Regeneron Pharmaceuticals
12.9.1 Regeneron Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Rare Inflammatory Disease Treatment Introduction
12.9.4 Regeneron Pharmaceuticals Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)
12.9.5 Regeneron Pharmaceuticals Recent Development
12.10 Swedish Orphan Biovitrum
12.10.1 Swedish Orphan Biovitrum Company Details
12.10.2 Company Description and Business Overview
12.10.3 Rare Inflammatory Disease Treatment Introduction
12.10.4 Swedish Orphan Biovitrum Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)
12.10.5 Swedish Orphan Biovitrum Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Rare Inflammatory Disease Treatment Key Market Segments
Table Key Players Rare Inflammatory Disease Treatment Covered
Table Global Rare Inflammatory Disease Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Rare Inflammatory Disease Treatment Market Size Market Share by Type 2014-2025
Figure Injectables Figures
Table Key Players of Injectables
Figure Oral Figures
Table Key Players of Oral
Figure Others Figures
Table Key Players of Others
Table Global Rare Inflammatory Disease Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Rare Inflammatory Disease Treatment Report Years Considered
Table Global Rare Inflammatory Disease Treatment Market Size 2014-2025 (Million US$)
Figure Global Rare Inflammatory Disease Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Rare Inflammatory Disease Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Rare Inflammatory Disease Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Rare Inflammatory Disease Treatment Market Share by Regions 2014-2019
Figure Global Rare Inflammatory Disease Treatment Market Share by Regions 2014-2019
Figure Global Rare Inflammatory Disease Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Rare Inflammatory Disease Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Rare Inflammatory Disease Treatment Market Share by Manufacturers (2014-2019)
Figure Global Rare Inflammatory Disease Treatment Market Share by Manufacturers in 2018
Table Global Rare Inflammatory Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Rare Inflammatory Disease Treatment Product/Solution/Service
Table Date of Enter into Rare Inflammatory Disease Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Rare Inflammatory Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Rare Inflammatory Disease Treatment Market Size Share by Type (2014-2019)
Figure Global Rare Inflammatory Disease Treatment Market Size Market Share by Type (2014-2019)
Table Global Rare Inflammatory Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Rare Inflammatory Disease Treatment Market Size Share by Application (2014-2019)
Figure Global Rare Inflammatory Disease Treatment Market Size Market Share by Application (2014-2019)
Figure Global Rare Inflammatory Disease Treatment Revenue Market Share by Application in 2018
Figure United States Rare Inflammatory Disease Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Rare Inflammatory Disease Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Rare Inflammatory Disease Treatment Market Share (2018-2019)
Table United States Rare Inflammatory Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Rare Inflammatory Disease Treatment Market Share by Type (2014-2019)
Table United States Rare Inflammatory Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Rare Inflammatory Disease Treatment Market Share by Application (2014-2019)
Figure Europe Rare Inflammatory Disease Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Rare Inflammatory Disease Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Rare Inflammatory Disease Treatment Market Share (2018-2019)
Table Europe Rare Inflammatory Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Rare Inflammatory Disease Treatment Market Share by Type (2014-2019)
Table Europe Rare Inflammatory Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Rare Inflammatory Disease Treatment Market Share by Application (2014-2019)
Figure China Rare Inflammatory Disease Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Rare Inflammatory Disease Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Rare Inflammatory Disease Treatment Market Share (2018-2019)
Table China Rare Inflammatory Disease Treatment Market Size by Type (2014-20189) (Million US$)
Table China Rare Inflammatory Disease Treatment Market Share by Type (2014-2019)
Table China Rare Inflammatory Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table China Rare Inflammatory Disease Treatment Market Share by Application (2014-2019)
Figure Japan Rare Inflammatory Disease Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Rare Inflammatory Disease Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Rare Inflammatory Disease Treatment Market Share (2018-2019)
Table Japan Rare Inflammatory Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Rare Inflammatory Disease Treatment Market Share by Type (2014-2019)
Table Japan Rare Inflammatory Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Rare Inflammatory Disease Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Rare Inflammatory Disease Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Rare Inflammatory Disease Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Rare Inflammatory Disease Treatment Market Share (2018-2019)
Table Southeast Asia Rare Inflammatory Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Rare Inflammatory Disease Treatment Market Share by Type (2014-2019)
Table Southeast Asia Rare Inflammatory Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Rare Inflammatory Disease Treatment Market Share by Application (2014-2019)
Figure India Rare Inflammatory Disease Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Rare Inflammatory Disease Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Rare Inflammatory Disease Treatment Market Share (2018-2019)
Table India Rare Inflammatory Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table India Rare Inflammatory Disease Treatment Market Share by Type (2014-2019)
Table India Rare Inflammatory Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table India Rare Inflammatory Disease Treatment Market Share by Application (2014-2019)
Figure Central & South America Rare Inflammatory Disease Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Rare Inflammatory Disease Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Rare Inflammatory Disease Treatment Market Share (2018-2019)
Table Central & South America Rare Inflammatory Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Rare Inflammatory Disease Treatment Market Share by Type (2014-2019)
Table Central & South America Rare Inflammatory Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Rare Inflammatory Disease Treatment Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Rare Inflammatory Disease Treatment Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Rare Inflammatory Disease Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Rare Inflammatory Disease Treatment Business (2014-2019)
Table Novartis Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Rare Inflammatory Disease Treatment Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Rare Inflammatory Disease Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Allergan Company Details
Table Allergan Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Rare Inflammatory Disease Treatment Business (2014-2019)
Table Allergan Recent Development
Table Abbvie Company Details
Table Abbvie Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)(Million US$)
Figure Abbvie Revenue Growth Rate in Rare Inflammatory Disease Treatment Business (2014-2019)
Table Abbvie Recent Development
Table Bausch Health Companies Company Details
Table Bausch Health Companies Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)(Million US$)
Figure Bausch Health Companies Revenue Growth Rate in Rare Inflammatory Disease Treatment Business (2014-2019)
Table Bausch Health Companies Recent Development
Table Mallinckrodt Company Details
Table Mallinckrodt Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)(Million US$)
Figure Mallinckrodt Revenue Growth Rate in Rare Inflammatory Disease Treatment Business (2014-2019)
Table Mallinckrodt Recent Development
Table Regeneron Pharmaceuticals Company Details
Table Regeneron Pharmaceuticals Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)(Million US$)
Figure Regeneron Pharmaceuticals Revenue Growth Rate in Rare Inflammatory Disease Treatment Business (2014-2019)
Table Regeneron Pharmaceuticals Recent Development
Table Swedish Orphan Biovitrum Company Details
Table Swedish Orphan Biovitrum Revenue in Rare Inflammatory Disease Treatment Business (2014-2019)(Million US$)
Figure Swedish Orphan Biovitrum Revenue Growth Rate in Rare Inflammatory Disease Treatment Business (2014-2019)
Table Swedish Orphan Biovitrum Recent Development
Table Global Rare Inflammatory Disease Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Rare Inflammatory Disease Treatment Market Size Share by Regions (2019-2025)
Figure Global Rare Inflammatory Disease Treatment Market Size Share by Regions in 2025
Figure United States Rare Inflammatory Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Rare Inflammatory Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Rare Inflammatory Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Rare Inflammatory Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Rare Inflammatory Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Rare Inflammatory Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Rare Inflammatory Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Rare Inflammatory Disease Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Rare Inflammatory Disease Treatment Market Size by Product (2019-2025)
Figure Global Rare Inflammatory Disease Treatment Market Size by Product in 2025
Table Global Rare Inflammatory Disease Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Rare Inflammatory Disease Treatment Market Size by Application (2019-2025)
Figure Global Rare Inflammatory Disease Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---